Inaktiver Wert

SCOLR Pharma Inc. Aktie

Aktien

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

SCOLR Pharma Inc. : SCOLR Pharma’s Partner to Commence Bioequivalence Study of Ondansetron	15.02.12
SCOLR Pharma Inc. : SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products	23.12.11
SCOLR PHARM : SCOLR Pharma, Inc. Announces Initial Closing of Private Placement	16.06.11
SCOLR PHARM : SCOLR Pharma, Inc. First Quarter 2011 Financial Results	09.05.11
SCOLR PHARM : SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference	03.05.11

Manager	Titel	Alter	Seit
Clem Calabrese SAM	Sales & Marketing	-	01.05.12

Aufsichtsräte	Titel	Alter	Seit
Michael Taglich CHM	Chairman	57	01.08.03
Herbert L. Lucas BRD	Director/Board Member	96	01.01.91
Randall L. W. Caudill BRD	Director/Board Member	76	01.01.02

Sektor

	% 1. Jan.	Kap.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.46%	44.39 Mrd.
OTSUKA HOLDINGS CO., LTD.	+20.08%	22.46 Mrd.
SANDOZ GROUP AG	+17.78%	15.04 Mrd.
CIPLA LIMITED	+19.79%	13.98 Mrd.
ZYDUS LIFESCIENCES LIMITED	+55.18%	13.15 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-10.55%	6.89 Mrd.
THE MEDICINES COMPANY	-0.05%	6.79 Mrd.
ASPEN PHARMACARE HOLDINGS LIMITED	+14.03%	5.71 Mrd.
STADA ARZNEIMITTEL	-8.87%	5.73 Mrd.